Pharmacologic inhibition of SOX9-CDK4 by CYD-4-61 impairs gastric adenocarcinoma growth and amplifies anti-PD-1 response. Zou G, Yoshimura K, Fan Y, Zeng L, et al. Cancer Lett 2026;659:218777.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zou G, Yoshimura K, Fan Y, Zeng L, et al. Pharmacologic inhibition of SOX9-CDK4 by CYD-4-61 impairs gastric adenocarcinoma growth and amplifies anti-PD-1 response. Cancer Lett 2026;659:218777.
PMID: 42567470